首页 | 本学科首页   官方微博 | 高级检索  
     

萨滞布病(脑中风)的藏医病因病机及干预策略研究
引用本文:贡保东知,阿达,完么才让,加羊加措,邱建智,张艺. 萨滞布病(脑中风)的藏医病因病机及干预策略研究[J]. 世界中医药, 2021, 16(15): 2250-2253
作者姓名:贡保东知  阿达  完么才让  加羊加措  邱建智  张艺
作者单位:甘肃中医药大学藏医学院,甘南,747000;甘肃中医药大学中医临床学院,兰州,730000;成都中医药大学民族医药学术传承创新研究中心,成都,611137;成都中医药大学民族医药学院,成都,611137
基金项目:国家社会科学基金重大项目(16ZDA238);国家重点研发计划项目(2017YFC1703904)
摘    要:萨滞布病是临床常见病和多发病,藏医药治疗萨滞布病临床疗效显著,但其病因病机尚存在异议,为促进和提高萨滞布病因病机的认识,本研究查阅和古籍文献,发现萨滞布病是人体三因失去平衡后隆血紊乱,人体坏血增多,坏血在隆的反作用下黏性增高,出现血液堵塞或溢出现象,导致白脉和黑脉受损,进而引起偏瘫、失语等症状,同时依据文献将萨滞布病的...

关 键 词:藏医  萨滞布病  脑中风  病因病机  研究策略  肠道菌群  代谢组学  味性化味
收稿时间:2021-06-10

Pathogenesis and Intervention Strategies of the Tibetan Medicine for gZav-Grib Disease (Cerebral Stroke)
GONPO Dhondrup,Ad,ME Cairang,GYANG Gyatso,QIU Jianzhi,ZHANG Yi. Pathogenesis and Intervention Strategies of the Tibetan Medicine for gZav-Grib Disease (Cerebral Stroke)[J]. World Chinese Medicine, 2021, 16(15): 2250-2253
Authors:GONPO Dhondrup  Ad  ME Cairang  GYANG Gyatso  QIU Jianzhi  ZHANG Yi
Affiliation:1 Tibetan Medical College, Gansu University of Traditional Chinese Medicine, Gannan 747000, China; 2 Clinical College of Traditional Chinese Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China; 3 Academic Inheritance and Innovation Research Center of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; 4 School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
Abstract:gZav-Grib disease is a common and multimorbidity disease, the clinical efficacy of Tibetan medicine for the treatment of gZav-Grib disease is significant by still controversial. In order to promote and improve the understanding of the etiological mechanisms of human diseases, we reviewed ancient literature and found that gZav-Grib disease is a disorder of human blood proliferation after the loss of balance, increased human blood loss, and increased blood viscosity with the opposing effects of brodifacoum. The phenomenon of blood clogging or spillover occurs, which leads to damage to the white and black veins and then causes symptoms such as hemiplegia and aphasia, while the syndromic classification of gZav-Grib disease is summarized and combed according to the literature. Based on the theory of Tibetan medicine and relevant literature from inside and outside China on the frontiers of Tibetan medicine, the strategy of Tibetan medicine to intervene in gZav-Grib disease from neurovascular unit, chronopharmacology, metabolomics, and intestinal flora has been proposed, which may provide an adaptor point for the theory of Tibetan medicine to intervene in gZav-Grib disease by new methods and ideas.
Keywords:
本文献已被 万方数据 等数据库收录!
点击此处可从《世界中医药》浏览原始摘要信息
点击此处可从《世界中医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号